Drug Index

Luliconazole

Mechanism :

Azole antifungal that appears to inhibit ergosterol synthesis by inhibiting the enzyme lanosterol demethylase, resulting in decreased amounts of ergosterol and a corresponding accumulation of lanosterol.


Indication :

  • Topical treatment of interdigital tinea pedis, tinea cruris, and tinea corporis caused by Trichophyton rubrum and Epidermophyton floccosum.

Contraindications :

No contraindications.


Dosing :

Topical Tinea pedis or tinea cruris:
Children ≥12 years and Adolescents:
Apply to affected area and ~1 inch of immediate surrounding areas once daily for 2 weeks.
Topical Tinea corporis:
Children ≥2 years and Adolescents:
Apply to affected area and ~1 inch of immediate surrounding areas once daily for 1 week.

Adverse Effect :

Application site reaction, cellulitis, contact dermatitis.


Interaction :

Cilostazol: CYP2C19 Inhibitors may increase the serum concentration of Cilostazol.



Hepatic Dose :

No dose adjustments are recommended.
07/13/2024 10:06:10 Luliconazole
Disclaimer: The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0